About Leinco Technologies
Leinco Technologies is a company based in St. Louis (United States) founded in 1992 was acquired by Ampersand Capital in November 2021. Leinco Technologies has completed 1 acquisition, including QED Bioscience. Leinco Technologies offers products and services including Antibodies, Proteins, and Custom Services. Leinco Technologies operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leinco Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1 M (USD), Grant
Feb 06, 2025
-
Investors
Gates Foundation
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Ampersand Capital
(Nov 17, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leinco Technologies
Leinco Technologies offers a comprehensive portfolio of products and services, including Antibodies, Proteins, and Custom Services.
High-quality antibodies for scientific and diagnostic applications
Recombinant proteins supporting life sciences research studies
Tailored antibody and protein production for research needs
People of Leinco Technologies
Unlock access to complete
Sales and Marketing
1 people
Leadership Team
1 people
R Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Leinco Technologies
Investors in Leinco Technologies
Leinco Technologies has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for Leinco Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leinco Technologies
Leinco Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include QED Bioscience.
Investment portfolio details for Leinco Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proteins and antibody reagents for research
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Leinco Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Leinco Technologies
Detailed financials for Leinco Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leinco Technologies Comparisons
Peer comparison for Leinco Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leinco Technologies
Leinco Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Leinco Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leinco Technologies
Complete news archive for Leinco Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leinco Technologies
Leinco Technologies was founded in 1992 and raised its 1st funding round 33 years after it was founded.
Leinco Technologies is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Leinco Technologies was founded in 1992 in St. Louis, United States, and operates within the life science research sector. Antibodies, proteins, in vitro diagnostic products, buffers, and reagents are produced and supplied, organized by research area, application, and antigen. Custom services are offered, including antibody development, cell line creation, protein production, lyophilization, and conjugation processes.
Leinco Technologies's top competitors include Sino Biological, GenScript and Y-Biologics.
Leinco Technologies offers Antibodies, Proteins, and Custom Services.
Leinco Technologies has made 1 acquisition, including QED Bioscience.
Leinco Technologies has 2 investors. Key investors include Gates Foundation, and Ampersand Capital Partners.